IKT
Inhibikase·NASDAQ
--
--(--)
--
--(--)
IKT fundamentals
Inhibikase (IKT) released its earnings on Aug 14, 2025: revenue was -- (YoY --), beat estimates; EPS was -0.11 (YoY +83.33%), missed estimates.
Revenue / YoY
--
--
EPS / YoY
-0.11
+83.33%
Report date
Aug 14, 2025
EPS
Actual | -1.08 | -1.14 | -1.08 | -1.08 | -1.08 | -1.08 | -0.96 | -1.11 | -0.86 | -0.64 | -0.73 | -0.66 | -0.65 | 0.88 | -0.15 | -0.11 |
Forecast | -0.84 | -1.02 | -1.02 | -1.14 | -1.08 | -1.14 | -0.87 | -0.92 | -1.12 | -0.85 | -0.79 | -0.67 | -0.48 | -0.0867 | -0.1 | -0.08 |
Surprise | -28.57% | -11.76% | -5.88% | +5.26% | 0.00% | +5.26% | -10.34% | -20.65% | +23.21% | +24.71% | +7.59% | +1.49% | -35.42% | +1114.99% | -50.00% | -37.50% |
Revenue
Actual | 328.46K | 0 | 46.03K | 6.55K | 7.29K | 53.44K | 64.52K | 116.41K | 79.57K | 501 | 0 | 0 | 0 | 0 | -- | -- |
Forecast | 200.00K | 300.00K | 300.00K | 300.00K | 200.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | +64.23% | -100.00% | -84.66% | -97.82% | -96.35% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
Did Inhibikase beat or miss consensus estimates last quarter?What were the key takeaways from Inhibikase's earnings call?What factors drove the changes in Inhibikase's revenue and profit?What is Inhibikase's latest dividend and current dividend yield?What guidance did Inhibikase's management provide for the next earnings period?What does Inhibikase do and what are its main business segments?What is the revenue and EPS growth rate for Inhibikase year over year?What is Inhibikase's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
